• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

运用并行 S-ADAPT 的蒙特卡罗重要性抽样算法在基本和复杂机械模型中的性能和稳健性。

Performance and robustness of the Monte Carlo importance sampling algorithm using parallelized S-ADAPT for basic and complex mechanistic models.

机构信息

Ordway Research Institute, Albany, New York 12208, USA.

出版信息

AAPS J. 2011 Jun;13(2):212-26. doi: 10.1208/s12248-011-9258-9. Epub 2011 Mar 4.

DOI:10.1208/s12248-011-9258-9
PMID:21374103
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3085700/
Abstract

The Monte Carlo Parametric Expectation Maximization (MC-PEM) algorithm can approximate the true log-likelihood as precisely as needed and is efficiently parallelizable. Our objectives were to evaluate an importance sampling version of the MC-PEM algorithm for mechanistic models and to qualify the default estimation settings in SADAPT-TRAN. We assessed bias, imprecision and robustness of this algorithm in S-ADAPT for mechanistic models with up to 45 simultaneously estimated structural parameters, 14 differential equations, and 10 dependent variables (one drug concentration and nine pharmacodynamic effects). Simpler models comprising 15 parameters were estimated using three of the ten dependent variables. We set initial estimates to 0.1 or 10 times the true value and evaluated 30 bootstrap replicates with frequent or sparse sampling. Datasets comprised three dose levels with 16 subjects each. For simultaneous estimation of the full model, the ratio of estimated to true values for structural model parameters (median [5-95% percentile] over 45 parameters) was 1.01 [0.94-1.13] for means and 0.99 [0.68-1.39] for between-subject variances for frequent sampling and 1.02 [0.81-1.47] for means and 1.02 [0.47-2.56] for variances for sparse sampling. Imprecision was ≤25% for 43 of 45 means for frequent sampling. Bias and imprecision was well comparable for the full and simpler models. Parallelized estimation was 23-fold (6.9-fold) faster using 48 threads (eight threads) relative to one thread. The MC-PEM algorithm was robust and provided unbiased and adequately precise means and variances during simultaneous estimation of complex, mechanistic models in a 45 dimensional parameter space with rich or sparse data using poor initial estimates.

摘要

蒙特卡罗参数期望最大化 (MC-PEM) 算法可以根据需要精确逼近真实对数似然,并且能够有效地进行并行化。我们的目标是评估用于机械模型的重要性抽样版本的 MC-PEM 算法,并对 SADAPT-TRAN 中的默认估计设置进行资格认证。我们评估了在 S-ADAPT 中,这种算法在多达 45 个同时估计的结构参数、14 个微分方程和 10 个因变量(一个药物浓度和 9 个药效学效应)的机械模型中的偏差、不精确性和稳健性。使用十个因变量中的三个,我们对包含 15 个参数的更简单的模型进行了估计。我们将初始估计值设置为真实值的 0.1 或 10 倍,并使用频繁或稀疏采样评估了 30 次自举复制。数据集由三个剂量水平组成,每个剂量水平有 16 个受试者。对于完整模型的同时估计,结构模型参数的估计值与真实值之比(45 个参数的中位数 [5-95% 分位数])对于频繁采样,均值为 1.01 [0.94-1.13],个体间方差为 0.99 [0.68-1.39],稀疏采样的均值为 1.02 [0.81-1.47],个体间方差为 1.02 [0.47-2.56]。对于频繁采样,43 个均值的不精确性≤25%。对于完整和更简单的模型,偏差和不精确性具有可比性。使用 48 个线程(8 个线程)进行并行化估计比使用 1 个线程分别快 23 倍(6.9 倍)和 1.5 倍。MC-PEM 算法在使用较差的初始估计值,对具有丰富或稀疏数据的 45 维参数空间中的复杂机械模型进行同时估计时具有稳健性,并提供无偏和足够精确的均值和方差。

相似文献

1
Performance and robustness of the Monte Carlo importance sampling algorithm using parallelized S-ADAPT for basic and complex mechanistic models.运用并行 S-ADAPT 的蒙特卡罗重要性抽样算法在基本和复杂机械模型中的性能和稳健性。
AAPS J. 2011 Jun;13(2):212-26. doi: 10.1208/s12248-011-9258-9. Epub 2011 Mar 4.
2
Development of a new pre- and post-processing tool (SADAPT-TRAN) for nonlinear mixed-effects modeling in S-ADAPT.开发一个新的 S-ADAPT 中非线性混合效应建模的预处理和后处理工具(SADAPT-TRAN)。
AAPS J. 2011 Jun;13(2):201-11. doi: 10.1208/s12248-011-9257-x. Epub 2011 Mar 3.
3
Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.参数和非参数总体方法:它们在分析临床数据集和两项蒙特卡罗模拟研究中的比较性能。
Clin Pharmacokinet. 2006;45(4):365-83. doi: 10.2165/00003088-200645040-00003.
4
Novel hybrid GPU-CPU implementation of parallelized Monte Carlo parametric expectation maximization estimation method for population pharmacokinetic data analysis.新型 GPU-CPU 混合并行化 Monte Carlo 参数期望极大化估计方法在群体药代动力学数据分析中的应用。
AAPS J. 2013 Oct;15(4):1212-21. doi: 10.1208/s12248-013-9524-0. Epub 2013 Sep 4.
5
Employing a Monte Carlo algorithm in expectation maximization restricted maximum likelihood estimation of the linear mixed model.运用蒙特卡罗算法在期望最大化限制最大似然估计线性混合模型中的应用。
J Anim Breed Genet. 2012 Dec;129(6):457-68. doi: 10.1111/j.1439-0388.2012.01000.x. Epub 2012 Apr 28.
6
Comparing the performance of FOCE and different expectation-maximization methods in handling complex population physiologically-based pharmacokinetic models.比较FOCE与不同期望最大化方法在处理复杂群体生理药代动力学模型方面的性能。
J Pharmacokinet Pharmacodyn. 2016 Aug;43(4):359-70. doi: 10.1007/s10928-016-9476-y. Epub 2016 May 23.
7
Employing a Monte Carlo algorithm in Newton-type methods for restricted maximum likelihood estimation of genetic parameters.在用于遗传参数限制最大似然估计的牛顿型方法中采用蒙特卡罗算法。
PLoS One. 2013 Dec 10;8(12):e80821. doi: 10.1371/journal.pone.0080821. eCollection 2013.
8
RPEM: Randomized Monte Carlo parametric expectation maximization algorithm.RPEM:随机蒙特卡罗参数期望最大化算法。
CPT Pharmacometrics Syst Pharmacol. 2024 May;13(5):759-780. doi: 10.1002/psp4.13113. Epub 2024 Apr 15.
9
Performance of different population pharmacokinetic algorithms.不同群体药代动力学算法的性能。
Ther Drug Monit. 2011 Oct;33(5):583-91. doi: 10.1097/FTD.0b013e318232bc61.
10
Applications of Monte Carlo Simulation in Modelling of Biochemical Processes蒙特卡罗模拟在生化过程建模中的应用

引用本文的文献

1
Population pharmacokinetic rationale for intravenous contezolid acefosamil followed by oral contezolid dosage regimens.群体药代动力学:注射用头孢洛林酯富马酸与口服头孢洛林酯给药方案的相关性。
Antimicrob Agents Chemother. 2024 Apr 3;68(4):e0140023. doi: 10.1128/aac.01400-23. Epub 2024 Feb 28.
2
Central Nervous System Antimicrobial Exposure and Proposed Dosing for Anthrax Meningitis.中枢神经系统抗菌药物暴露和炭疽性脑膜炎的推荐剂量。
Clin Infect Dis. 2024 Jun 14;78(6):1451-1457. doi: 10.1093/cid/ciae093.
3
Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in .鉴定并数学建模与耐头孢他啶/他唑巴坦相关的细胞外代谢标志物的时间过程。
Antimicrob Agents Chemother. 2024 Apr 3;68(4):e0108123. doi: 10.1128/aac.01081-23. Epub 2024 Feb 20.
4
Comprehensive stability analysis of 13 β-lactams and β-lactamase inhibitors in media, and novel supplement dosing strategy to mitigate thermal drug degradation.在介质中对 13 种β-内酰胺类抗生素和β-内酰胺酶抑制剂进行综合稳定性分析,并提出新的补充剂量策略以减轻热药物降解。
Antimicrob Agents Chemother. 2024 Mar 6;68(3):e0139923. doi: 10.1128/aac.01399-23. Epub 2024 Feb 8.
5
Population pharmacokinetics and humanized dosage regimens matching the peak, area, trough, and range of amikacin plasma concentrations in immune-competent murine bloodstream and lung infection models.人群药代动力学和基于氨基糖苷类药物血药峰浓度、药时曲线下面积、谷浓度及波动度的人优化给药方案在免疫正常的鼠血流感染和肺部感染模型中的应用。
Antimicrob Agents Chemother. 2024 Mar 6;68(3):e0139423. doi: 10.1128/aac.01394-23. Epub 2024 Jan 30.
6
Improved characterization of aminoglycoside penetration into human lung epithelial lining fluid via population pharmacokinetics.通过群体药代动力学改善对氨基糖苷类药物渗透入人肺上皮衬液的特性描述。
Antimicrob Agents Chemother. 2024 Feb 7;68(2):e0139323. doi: 10.1128/aac.01393-23. Epub 2024 Jan 3.
7
Ceftolozane-Tazobactam against Pseudomonas aeruginosa Cystic Fibrosis Clinical Isolates in the Hollow-Fiber Infection Model: Challenges Imposed by Hypermutability and Heteroresistance.头孢洛扎他唑巴坦对囊性纤维化临床分离的铜绿假单胞菌在中空纤维感染模型中的作用:高突变率和异质性耐药带来的挑战。
Antimicrob Agents Chemother. 2023 Aug 17;67(8):e0041423. doi: 10.1128/aac.00414-23. Epub 2023 Jul 10.
8
Central and peripheral lung deposition of fluticasone propionate dry powder inhaler formulations in humans characterized by population pharmacokinetics.应用群体药代动力学特征描述丙酸氟替卡松干粉吸入剂在人体中的肺部中央和周边沉积。
Pharm Res. 2023 May;40(5):1177-1191. doi: 10.1007/s11095-023-03472-6. Epub 2023 Apr 20.
9
Individual Components of Polymyxin B Modeled via Population Pharmacokinetics to Design Humanized Dosage Regimens for a Bloodstream and Lung Infection Model in Immune-Competent Mice.通过群体药代动力学模拟多粘菌素 B 的各个成分,为免疫功能正常的小鼠的血流和肺部感染模型设计人性化的剂量方案。
Antimicrob Agents Chemother. 2023 May 17;67(5):e0019723. doi: 10.1128/aac.00197-23. Epub 2023 Apr 6.
10
Penicillin G concentrations required for prophylaxis against Group A Streptococcus infection evaluated using a hollow fibre model and mathematical modelling.使用中空纤维模型和数学模型评估预防 A 组链球菌感染所需的青霉素 G 浓度。
J Antimicrob Chemother. 2022 Jun 29;77(7):1923-1930. doi: 10.1093/jac/dkac124.

本文引用的文献

1
Mechanism-based pharmacokinetic/pharmacodynamic model for troxacitabine-induced neutropenia in cancer patients.基于机制的曲沙他滨致癌症患者中性粒细胞减少症的药代动力学/药效学模型。
Cancer Chemother Pharmacol. 2011 May;67(5):985-94. doi: 10.1007/s00280-010-1393-y. Epub 2010 Jul 8.
2
Simultaneous pharmacokinetics/pharmacodynamics modeling of recombinant human erythropoietin upon multiple intravenous dosing in rats.在大鼠中多次静脉注射重组人促红细胞生成素的药代动力学/药效学同步建模。
J Pharmacol Exp Ther. 2010 Sep 1;334(3):897-910. doi: 10.1124/jpet.110.167304. Epub 2010 May 25.
3
Attenuation of colistin bactericidal activity by high inoculum of Pseudomonas aeruginosa characterized by a new mechanism-based population pharmacodynamic model.高接种量铜绿假单胞菌对黏菌素杀菌活性的衰减作用及其基于新作用机制的群体药动学模型。
Antimicrob Agents Chemother. 2010 May;54(5):2051-62. doi: 10.1128/AAC.00881-09. Epub 2010 Mar 8.
4
Population pharmacokinetic modelling of filgrastim in healthy adults following intravenous and subcutaneous administrations.健康成年人静脉注射和皮下注射粒细胞集落刺激因子的群体药代动力学模型研究。
Clin Pharmacokinet. 2009;48(12):817-26. doi: 10.2165/11318090-000000000-00000.
5
Nonlinear Random Effects Mixture Models: Maximum Likelihood Estimation via the EM Algorithm.非线性随机效应混合模型:通过期望最大化(EM)算法进行最大似然估计
Comput Stat Data Anal. 2007 Aug 15;51(12):6614-6623. doi: 10.1016/j.csda.2007.03.008.
6
Performance in population models for count data, part I: maximum likelihood approximations.计数数据总体模型中的性能,第一部分:最大似然近似。
J Pharmacokinet Pharmacodyn. 2009 Aug;36(4):353-66. doi: 10.1007/s10928-009-9126-8. Epub 2009 Aug 4.
7
A comprehensive model for the humoral coagulation network in humans.人类体液凝血网络的综合模型。
Clin Pharmacol Ther. 2009 Sep;86(3):290-8. doi: 10.1038/clpt.2009.87. Epub 2009 Jun 10.
8
Mechanism-based receptor-binding model to describe the pharmacokinetic and pharmacodynamic of an anti-α5β1 integrin monoclonal antibody (volociximab) in cancer patients.基于机制的受体结合模型描述了抗α5β1 整联蛋白单克隆抗体(volociximab)在癌症患者中的药代动力学和药效学。
Cancer Chemother Pharmacol. 2010 Jan;65(2):207-17. doi: 10.1007/s00280-009-1023-8.
9
Mechanism-based modeling of nutritional and leptin influences on growth in normal and type 2 diabetic rats.基于机制的营养和瘦素对正常及2型糖尿病大鼠生长影响的建模
J Pharmacol Exp Ther. 2009 Feb;328(2):644-51. doi: 10.1124/jpet.108.144766. Epub 2008 Oct 29.
10
Development and qualification of a pharmacodynamic model for the pronounced inoculum effect of ceftazidime against Pseudomonas aeruginosa.头孢他啶对铜绿假单胞菌显著接种物效应的药效学模型的建立与验证
Antimicrob Agents Chemother. 2009 Jan;53(1):46-56. doi: 10.1128/AAC.00489-08. Epub 2008 Oct 13.